CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke
Mi-Yeon Eun, Jae-Young Kim, Yang-Ha Hwang, Man-Seok Park, Joon-Tae Kim, Kang-Ho Choi, Jin-Man Jung, Sungwook Yu, Chi Kyung Kim, Kyungmi Oh, Tae-Jin Song, Yong-Jae Kim, Bum Joon Kim, Sung Hyuk Heo, Kwang-Yeol Park, Jeong-Min Kim, Jong-Ho Park, Jay Chol Choi, Jong-Won Chung, Oh Young Bang, Gyeong-Moon Kim, Woo-Keun Seo
J Stroke. 2021;23(1):113-123.   Published online January 31, 2021
DOI: https://doi.org/10.5853/jos.2020.03440

Excel Download

Oral Anticoagulant Use Around the Time of Atrial Fibrillation Ablation: A Review of the Current Evidence of Individual Oral Anticoagulant Use for Periprocedural Atrial Fibrillation Ablation Thromboembolic Prophylaxis
ALEX B. GARTON, JOHN DUDZINSKI, PETER R. KOWEY
Journal of Cardiovascular Electrophysiology. 2014;25(12):1411-1418   Crossref logo
Link1 Link2 Link3
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
Alexander G G Turpie
Therapeutics and Clinical Risk Management. 2014;197   Crossref logo
Link1
Guideline‐concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part D
Nicolae Done, Amanda M. Roy, Yingzhe Yuan, Steven D. Pizer, Adam J. Rose, Julia C. Prentice
Health Services Research. 2018;54(1):128-138   Crossref logo
Link1 Link2 Link3 Link4
CV4 BUDGET IMPACT OF CHANGING ORAL ANTICOAGULANT PRESCRIBING TO PREVENT ATRIAL-FIBRILLATION-RELATED STROKE IN ENGLAND
A. Orlowski, J.H. Wu, J. Wilkins, W. Smith
Value in Health. 2019;22:S38-S39   Crossref logo
Link1 Link2
PCV113 DIFFERENCE-IN-DIFFERENCES ANALYSIS OF THE IMPACT OF ORAL ANTICOAGULANT PRESCRIBING ON INCIDENCE OF ATRIAL-FIBRILLATION-RELATED STROKE
A. Orlowski, J.H. Wu, J. Wilkins, W. Smith
Value in Health. 2019;22:S139   Crossref logo
Link1 Link2
Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation
Hope Hua, Nicole Sur, Lilly Lee, Seemant Chaturvedi
Journal of Stroke and Cerebrovascular Diseases. 2021;30(2):105474   Crossref logo
Link1 Link2
Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke
Mi-Yeon Eun, Jae-Young Kim, Yang-Ha Hwang, Man-Seok Park, Joon-Tae Kim, Kang-Ho Choi, Jin-Man Jung, Sungwook Yu, Chi Kyung Kim, Kyungmi Oh, Tae-Jin Song, Yong-Jae Kim, Bum Joon Kim, Sung Hyuk Heo, Kwang-Yeol Park, Jeong-Min Kim, Jong-Ho Park, Jay Chol Choi, Jong-Won Chung, Oh Young Bang, Gyeong-Moon Kim, Woo-Keun Seo
Journal of Stroke. 2021;23(1):113-123   Crossref logo
Link1 Link2 Link3
Which anticoagulant for stroke prevention in atrial fibrillation?
Jocasta Ball
BMJ. 2017;j5399   Crossref logo
Link1 Link2
Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation
Lester Y. Leung, Mark McAllister, Magdy Selim, Marc Fisher
Journal of Stroke. 2017;19(2):232-235   Crossref logo
Link1 Link2 Link3
Paradoxical Procoagulant Effect of Early Doses of Warfarin: Possible Role of Non-Vitamin K Oral Anticoagulant in Patients with Atrial Fibrillation-Related Stroke
Yesel Kim, Oh Young Bang
Journal of Stroke. 2015;17(2):216   Crossref logo
Link1 Link2 Link3